Sphera Funds Management’s Albireo Pharma Inc ALBO Stock Holding History

Sphera Funds Management’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-463,828	Closed	-$10M	–	100
2022 Q4	$10M	Buy	463,828 +104,828	+29%	+$2.22M	2.15%	10
2022 Q3	$6.95M	Buy	+359,000	New	+$7.42M	0.96%	33
2020 Q4	–	Sell	-173,600	Closed	-$5.79M	–	136
2020 Q3	$5.79M	Buy	+173,600	New	+$5.06M	0.57%	50
2018 Q1	–	Sell	-35,431	Closed	-$907K	–	154
2017 Q4	$907K	Sell	35,431 -73,095	-67%	-$1.85M	0.11%	114
2017 Q3	$2.27M	Buy	108,526 +5,000	+5%	+$119K	0.32%	79
2017 Q2	$2.13M	Buy	+103,526	New	+$2.12M	0.36%	80
2014 Q2	–	Sell	-9,463	Closed	-$775K	–	138
2014 Q1	$775K	Buy	+9,463	New	+$861K	0.18%	95

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sphera Funds Management's ALBO Position: Q1 2023 in Review

Sphera Funds Management sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 463,828 shares — an estimated $10M sold.

Sphera Funds Management first reported a position in ALBO in Q1 2014 and held it in 7 quarters. The position peaked at $10M in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Sphera Funds Management reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Sphera Funds Management sold 463,828 Albireo Pharma Inc shares in Q1 2023, an estimated $10M.
Sphera Funds Management first reported a position in Albireo Pharma Inc in Q1 2014 and held it in 7 quarters.
Sphera Funds Management's Albireo Pharma Inc position peaked at $10M in Q4 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Sphera Funds Management's 13F filing for Q1 2023, filed 15 May 2023.